In vitro efficacy of antibiotics against different Borrelia isolates
Authors:
- 1 September 2021
- journal article
- research article
- Published by Akademiai Kiado Zrt. in Acta Microbiologica Et Immunologica Hungarica
- Vol. 68 (3) , 195-202
Abstract
In the present study, the effectiveness of six antimicrobial agents have been tested against 24 borrelia strains isolated from Ixodes ricinus ticks (11 Borrelia lusitaniae, eight Borrelia afzelii, three Borrelia garinii and two Borrelia valaisiana) and one B. lusitaniae strain isolated from human skin. The minimum inhibitory concentration range of antimicrobial agents was as follows: amoxicillin, 0.125-2 mg/L; doxycycline, 0.125-1 mg/L, ceftriaxone, 0.016-0.063 mg/L; cefuroxime, 0.063-1 mg/L; azithromycin, 0.0017-0.11 mg/L; amikacin 32-512 mg/L. Potentially pathogenic B. lusitaniae and B. valaisiana species were more susceptible to amoxicillin and azithromycin than pathogenic B. afzelii and B. garinii (P < 0.05); B. garinii, B. lusitaniae and B. valaisiana were more susceptible to doxycycline than B. afzelii (P < 0.05) while all species showed same susceptibility to ceftriaxone and cefuroxime (P > 0.05). This study is the first report on in vitro susceptibility of isolates from Serbia to antimicrobial agents and the first report on susceptibility of larger number of isolates of potentially pathogenic species B. lusitaniae. We showed that antimicrobial agents in vitro inhibit growth of borrelia strains very effectively, indicating the potential of their equally beneficial use in the treatment of Lyme borreliosis.Keywords
Funding Information
- Ministry of Education, Science and Technological Development, Republic of Serbia (451-03-9/2021-14/200015)
This publication has 32 references indexed in Scilit:
- In vitro susceptibility of European human Borrelia burgdorferi sensu stricto strains to antimicrobial agentsInternational Journal of Antimicrobial Agents, 2013
- In Vitro Susceptibility of Borrelia spielmanii to Antimicrobial Agents Commonly Used for Treatment of Lyme DiseaseAntimicrobial Agents and Chemotherapy, 2009
- In vitro activity of tigecycline against multiple strains of Borrelia burgdorferiJournal of Antimicrobial Chemotherapy, 2009
- Effect of Protein Binding on the Pharmacological Activity of Highly Bound AntibioticsAntimicrobial Agents and Chemotherapy, 2008
- Borrelia burgdorferi sensu lato, Anaplasma phagocytophilum, Francisella tularensis and their co-infections in host-seeking Ixodes ricinus ticks collected in SerbiaExperimental and Applied Acarology, 2008
- Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: What we know, what we don't know, and what we need to knowWiener klinische Wochenschrift, 2006
- In Vitro Susceptibility Testing of Four Antibiotics against Borrelia burgdorferi : a Comparison of Results for the Three Genospecies Borrelia afzelii , Borrelia garinii , and Borrelia burgdorferi Sensu StrictoJournal of Clinical Microbiology, 2003
- Distribution ofBorrelia burgdorferisensu lato inIxodes ricinus(Acari: Ixodidae) Ticks from the Basque Country, SpainJournal of Medical Entomology, 2002
- Kill kinetics ofBorrelia burgdorferi and bacterial findings in relation to the treatment of lyme borreliosisInfection, 1996
- In vitro Antimicrobial Susceptibility Testing of Borrelia burgdorferi: Influence of Test Conditions on Minimal Inhibitory Concentration (MIC) ValuesZentralblatt für Bakteriologie, 1995